NUSAJAYA: Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp) is confident of achieving the targeted 160,000 workers needed by the bio-based economy in 2020.
Its chief operating officer Razwin Sulairee Hasnan Termizi said the optimism was based on the "sexiness" of the industry, as it has the edge that blends with the interest and enthusiasm of Generations Y and Z.
"We believe we can attract the talent to the field. We just need to give youths some exposure to biotechnology and excite them to the "sexiness" of the industry," Razwin said, adding that the entry-level salary is also competitive.
Razwin said this before the launch of the Purple Fiesta, a two-day event that aims to attract over 400 participants.
"The event is a step forward for BiotechCorp to boost the bioeconomy workforce," said Razwin, who is also the chief executive officer of Bio-XCell Malaysia Sdn Bhd.
At the launch of the career campaign today, there were more than 270 university graduates, lecturers and industry players from the University of Kuala Lumpur (Malacca), Politeknik Nilai, Universiti Teknologi Malaysia, Universiti Teknologi MARA Johor, Universiti Malaysia Pahang, Universiti Tun Hussein Onn Malaysia, Newcastle University Medicine Malaysia and Manipal International University.
The inaugural event which was held at Bio-XCell, a premier custom-built biotechnology park set up by BiotechCorp and UEM Sunrise Berhad, featured career coaching and corporate grooming.
Razwin also said that the prime investments in Johor are the oil and gas, and food and agricultural sector, and he hopes to infuse biotechnology into these segments as a leverage.
"We can add value to what the state already has and the availability of raw materials found here. We can develop our own niche, which also includes focusing on the industrial sector, for instance," he said.
BiotechCorp is the bio-based economic development agency under the purview of the Ministry of Science, Technology and Innovation (MOSTI) to provide support, facilitation and advisory services for biotech and life sciences companies nation-wide.
On the 267 bionexus companies set up nationwide, Razwin said a few are in the pipelines for a listing on Bursa next year to enable them to penetrate the global market.